Glenmark Pharmaceuticals Ltd NSE  /  BSE

Pharmaceuticals, Mid Cap

14 May 2021 | 03:59 PM

607.85
-16.00 (-2.56%)

  • Outperforms Index

    75.48%

    Return (1Y)

    Beaten S&P BSE Healthcare by 15.97%

  • More Volatile

    2.92%

    Standard Deviation (1Y)

    Higher than S&P BSE Healthcare by 1.66%

  • Not so consistent

    4/12

    Months

    underperformed S&P BSE Healthcare

  • AxisDirect View

    No View

52 Week High-Low

640

640.30

326

325.80

News & Announcements

Currently there are no records found for News & Announcements.

Price vs Volume

Stock Trivia

  • Glenmark Pharmaceuticals Ltd is trading very close to its 52 Week High

  • FII shareholding in Glenmark Pharmaceuticals Ltd has decreased by -9.36% since past 1 Year

  • MF shareholding in Glenmark Pharmaceuticals Ltd has decreased by -12.6% since past 1 Year

Loading...